Cargando…

Calciphylaxis associated with the fibroblast growth factor receptor inhibitor erdafitinib

Detalles Bibliográficos
Autores principales:	Macklis, Paul, Chung, Catherine, Kaffenberger, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777177/ https://www.ncbi.nlm.nih.gov/pubmed/33426250 http://dx.doi.org/10.1016/j.jdcr.2020.11.022

Ejemplares similares

Fibroblast Growth Factor Receptor 3 Amplified Metastatic Melanoma Treated With Erdafitinib
por: Sarkisian, Saro, et al.
Publicado: (2020)

Stage 4 pancreatic adenocarcinoma harbouring an FGFR2-TACC2 fusion mutation with complete response to erdafitinib a pan-fibroblastic growth factor receptor inhibitor
por: Poon, Donald, et al.
Publicado: (2021)

Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib
por: de Almeida Carvalho, Lelia Maria, et al.
Publicado: (2019)

TRLS-08. EXPERIENCE WITH THE SELECTIVE FIBROBLAST GROWTH FACTOR INHIBITOR ERDAFITINIB IN THREE PEDIATRIC PATIENTS WITH CNS TUMORS
por: Stepien, Natalia, et al.
Publicado: (2023)

Calciphylaxis Cutis Associated With Fibroblast Growth Factor Receptor (FGFR) Inhibitor Therapy: A New Challenge
por: Griffith, Paige, et al.
Publicado: (2022)

Severe onycholysis and eyelash trichomegaly in a patient treated with erdafitinib
por: Deutsch, Alana, et al.
Publicado: (2020)

Thyroid dysfunction from inhibitor of fibroblast growth factor receptor
por: Ahn, Jeffrey, et al.
Publicado: (2019)

Reversible Retinopathy Associated with Fibroblast Growth Factor Receptor Inhibitor
por: Patel, Saagar N., et al.
Publicado: (2022)

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines
por: Lacouture, Mario E., et al.
Publicado: (2020)

Precision medicine: Sustained response to erdafitinib in FGFR2 ‐mutant, multiply recurrent ameloblastoma
por: Lawson‐Michod, Katherine A., et al.
Publicado: (2022)

Calciphylaxis: The potential diagnostic role of radiologists
por: Burdorf, Benjamin T.
Publicado: (2020)

Calciphylaxis - Case Report
por: Prohic, Nejra, et al.
Publicado: (2020)

Erdafitinib for locally advanced or metastatic urothelial carcinoma
por: Siefker-Radtke, Arlene O, et al.
Publicado: (2022)

Serous Retinopathy Associated With Combination MEK and Fibroblast Growth Factor Receptor Inhibitor
por: Day, H. Russell, et al.
Publicado: (2023)

Digital gangrene and pneumatosis intestinalis associated with calciphylaxis
por: Kawaji, Qingwen, et al.
Publicado: (2018)

Nonuremic Calciphylaxis Associated With Hypercalcemia and Rheumatologic Diseases
por: Vatanapradith, Athip, et al.
Publicado: (2021)

Calciphylaxis
por: Harb, Jennifer, et al.
Publicado: (2015)

Calciphylaxis in chronic renal failure: An approach to risk factors
por: Rezaie, W., et al.
Publicado: (2009)

Trichiasis and dry eye syndrome in two patients on novel fibroblast growth factor receptor inhibitor therapies
por: Vinson, Kyle B., et al.
Publicado: (2020)

Calciphylaxis in a Patient on Home Hemodialysis
por: Adapa, Sreedhar, et al.
Publicado: (2020)

A Fatal Case of Penile Calciphylaxis
por: D’Assumpcao, Carlos, et al.
Publicado: (2022)

Retinal artery and vein occlusion in calciphylaxis
por: Naranjo, Andrea, et al.
Publicado: (2022)

Distinguishing dystrophic calcification from calciphylaxis
por: Jones, Elizabeth, et al.
Publicado: (2023)

The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
por: Khalpey, Zain, et al.
Publicado: (2010)

Concomitant calciphylaxis and COVID-19 associated thrombotic retiform purpura
por: Rotman, Jessica A., et al.
Publicado: (2020)

Successful Treatment and Retreatment With Erdafitinib for a Patient With FGFR3-TACC3 Fusion Squamous NSCLC: A Case Report
por: Pham, Chi, et al.
Publicado: (2023)

Calciphylaxis following kidney transplantation: a case report
por: Hanvesakul, Rajesh, et al.
Publicado: (2009)

Calciphylaxis or vascular oxalosis?
por: El-Saygeh, Skye, et al.
Publicado: (2020)

Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment
por: Wang, Songbai, et al.
Publicado: (2020)

Penile Calciphylaxis in End Stage Renal Disease
por: Barbera, Vincenzo, et al.
Publicado: (2013)

Severe Systemic Calciphylaxis in a Young Cat
por: Anfinsen, K.P., et al.
Publicado: (2014)

Gastric Pneumatosis from Isolated Gastric Calciphylaxis
por: Mulgund, Aditi, et al.
Publicado: (2017)

Nonuremic calciphylaxis manifesting with diffuse dermal angiomatosis
por: Castillo, Francine T., et al.
Publicado: (2022)

Calciphylaxis of the Postmenopausal Female Breast: An Uncommonly Encountered Mimic of Carcinoma
por: Novotny, Aaron G., et al.
Publicado: (2017)

Severe necrosis of the glans penis associated with calciphylaxis treated by partial penectomy
por: Tezuka, Masato, et al.
Publicado: (2020)

Non-uremic calciphylaxis associated with alcoholic hepatitis: A case report
por: Sammour, Yasser M, et al.
Publicado: (2019)

Fibroblast growth factor receptor inhibitor therapy induced calcinosis cutis treated with sodium thiosulfate
por: Qian, Justin, et al.
Publicado: (2022)

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells
por: Feng, Weiguo, et al.
Publicado: (2020)

Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma
por: Sayegh, Nicolas, et al.
Publicado: (2022)

Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis
por: Rouvinov, Keren, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kibmpj3mf2d3rk7g0gjv58rie8